An open label, registry study of the safety of ILUVIEN® 190 micrograms intravitreal implant in applicator (IRISS)

20/09/2016
14/03/2024
EU PAS number:
EUPAS15411
Study
Finalised
Documents
Study protocol
Initial protocol
English (258.44 KB - PDF) View document
Study results
Study results
English (50.09 KB - PDF) View document
Study report
Other information
Publications